| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 18.07.2019 og
angivet som gældende fra 17.07.2019 (1946
dage). |
Ingen historik.
| Branche | | Forskning og eksperimentel udvikling indenfor bioteknologi (721100). |
| Sidst opdateret den 18.07.2019 og
angivet som gældende fra 17.07.2019 (1946
dage). |
Ingen historik.
| Revisionfravalgt | | false. |
| Sidst opdateret den 18.07.2019 og
angivet som gældende fra 17.07.2019 (1946
dage). |
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
| Navne | | Biograil ApS. |
| Sidst opdateret den 18.07.2019 og
angivet som gældende fra 17.07.2019 (1946
dage). |
Ingen historik.
| Tegningsregel | | Selskabet tegnes af en direktør. |
| Sidst opdateret den 18.07.2019 og
angivet som gældende fra 17.07.2019 (1946
dage). |
| Fortolkning
(1 tegningsmulighed)
| | 1 direktør |
Ingen historik.
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:Beierholm
Revisionsvirksomhedens CVR-nr.:32895468
Beskrivelse af revisor:State Authorized Public Accountant
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):The item other long-term liabilities includes derivative financial instruments with an amount of DKK 10. 165k. The liabilities are measured at fair value according to the management's estimate. We have not been able to obtain the necessary documentation for the determined fair value and are therefore not able to assess the management's estimate and the value of the liabilities.
We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the “Auditor’s responsibilities for the audit of the financial statements” section of our report. We are independent of the company in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):In our opinion, except for the possible effects of the matter described in the Basis for qualified opinion paragraph, the financial statements give a true and fair view of the company's financial position at 31. 12. 23 and of the results of the company's operations for the financial year 01. 01. 23 - 31. 12. 23 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Management is responsible for the management’s review.
Our opinion on the financial statements døs not cover the management’s review, and we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, it is our responsibility is to read management’s review and, in doing so, consider whether management’s review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated.
Moreover, it is our responsibility to consider whether management’s review provides the information required under the Danish Financial Statements Act.
Based on the work we have performed, we conclude that the management’s review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of the management’s review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration